|
|
|
|
| LEADER |
02527nam a22004215i 4500 |
| 001 |
978-0-387-32956-7 |
| 005 |
20191026062718.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2006 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9780387329567
|
| 024 |
7 |
|
|a 10.1007/0-387-32956-0
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 100 |
1 |
|
|a Janson, Christopher.
|e author.
|
| 245 |
1 |
0 |
|a Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules
|c by Christopher Janson, Matthew During.
|
| 250 |
|
|
|a 1st ed. 2006.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 2006.
|
| 300 |
|
|
|a XX, 274 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Medical Intelligence Unit
|
| 505 |
0 |
|
|a Research Applications -- The Many Faces of PNA -- Modulation of Nucleic Acid Information Processing by PNAs -- Targeted Gene Delivery -- Imaging Gene Expression in the Brain with Peptide Nucleic Acid (PNA) Antisense Radiopharmaceuticals and Drug Targeting Technology -- Receptor-Specific Targeting with Complementary Peptide Nucleic Acids Conjugated to Peptide Analogs and Radionuclides -- Morpholinos and PNAs Compared -- Chemistry of Locked Nucleic Acids (LNA) -- Recent Applications of RNA Interference (RNAi) in Mammalian Systems -- Clinical Applications -- Peptide Nucleic Acids as Epigenetic Inhibitors of HIV-1 -- Therapeutic Uses of Peptide Nucleic Acids (PNA) in Oncology -- PNAs as Novel Cancer Therapeutics -- Medicinal Chemistry of Plasmid DNA with Peptide Nucleic Acids -- Locked Nucleic Acids (LNA) and Medical Applications -- Peptide Nucleic Acids as Agents to Modify Target Gene Expression and Function -- Peptide Nucleic Acids -- The Use of PNAs and Their Derivatives in Mitochondrial Gene Therapy -- Gene Silencing through RNA Interference -- Transcriptional Activation of Human CREB Gene Promoter Using Bis-PNA (Peptide Nucleic Acid).
|
| 650 |
|
0 |
|a Human genetics.
|
| 650 |
|
0 |
|a Medical biochemistry.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
|
0 |
|a Biotechnology.
|
| 650 |
|
0 |
|a Biochemistry.
|
| 650 |
1 |
4 |
|a Human Genetics.
|
| 650 |
2 |
4 |
|a Medical Biochemistry.
|
| 650 |
2 |
4 |
|a Immunology.
|
| 650 |
2 |
4 |
|a Neurosciences.
|
| 650 |
2 |
4 |
|a Biotechnology.
|
| 650 |
2 |
4 |
|a Biochemistry, general.
|
| 700 |
1 |
|
|a During, Matthew.
|e author.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/0-387-32956-0
|